nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—Pulmonary eosinophilia—Dapsone—leprosy	0.0752	0.0922	CcSEcCtD
Ramipril—ACE—hindlimb—leprosy	0.0317	0.172	CbGeAlD
Ramipril—ACE—arm—leprosy	0.0303	0.164	CbGeAlD
Ramipril—ACE—appendage—leprosy	0.0272	0.147	CbGeAlD
Ramipril—ACE—peripheral nervous system—leprosy	0.0247	0.134	CbGeAlD
Ramipril—Polyneuropathy—Thalidomide—leprosy	0.0216	0.0265	CcSEcCtD
Ramipril—ACE—nerve—leprosy	0.0193	0.105	CbGeAlD
Ramipril—Proteinuria—Dapsone—leprosy	0.0156	0.0192	CcSEcCtD
Ramipril—Protein urine present—Dapsone—leprosy	0.0154	0.0189	CcSEcCtD
Ramipril—ACE—blood vessel—leprosy	0.0152	0.0821	CbGeAlD
Ramipril—Cerebral ischaemia—Thalidomide—leprosy	0.0146	0.0178	CcSEcCtD
Ramipril—Peripheral vascular disorder—Thalidomide—leprosy	0.0143	0.0176	CcSEcCtD
Ramipril—White blood cell count decreased—Thalidomide—leprosy	0.0141	0.0173	CcSEcCtD
Ramipril—Transient ischaemic attack—Thalidomide—leprosy	0.0139	0.0171	CcSEcCtD
Ramipril—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.0121	0.0148	CcSEcCtD
Ramipril—Psoriasis—Thalidomide—leprosy	0.0112	0.0137	CcSEcCtD
Ramipril—Neuralgia—Thalidomide—leprosy	0.0101	0.0124	CcSEcCtD
Ramipril—Burning sensation—Thalidomide—leprosy	0.0101	0.0124	CcSEcCtD
Ramipril—Myocardial ischaemia—Thalidomide—leprosy	0.00875	0.0107	CcSEcCtD
Ramipril—Influenza—Dapsone—leprosy	0.00862	0.0106	CcSEcCtD
Ramipril—Endocrine disorder—Thalidomide—leprosy	0.00848	0.0104	CcSEcCtD
Ramipril—Pancreatitis—Dapsone—leprosy	0.00845	0.0104	CcSEcCtD
Ramipril—ACE—eye—leprosy	0.00806	0.0437	CbGeAlD
Ramipril—Jaundice cholestatic—Thalidomide—leprosy	0.008	0.00982	CcSEcCtD
Ramipril—Proteinuria—Thalidomide—leprosy	0.008	0.00982	CcSEcCtD
Ramipril—Protein urine present—Thalidomide—leprosy	0.00789	0.00968	CcSEcCtD
Ramipril—Photosensitivity reaction—Dapsone—leprosy	0.00787	0.00965	CcSEcCtD
Ramipril—Drug interaction—Thalidomide—leprosy	0.00758	0.0093	CcSEcCtD
Ramipril—Neuropathy peripheral—Dapsone—leprosy	0.00753	0.00924	CcSEcCtD
Ramipril—Leukocytosis—Thalidomide—leprosy	0.00748	0.00918	CcSEcCtD
Ramipril—Hearing impaired—Thalidomide—leprosy	0.00739	0.00906	CcSEcCtD
Ramipril—Creatinine increased—Thalidomide—leprosy	0.00739	0.00906	CcSEcCtD
Ramipril—Sinusitis—Dapsone—leprosy	0.00721	0.00884	CcSEcCtD
Ramipril—Hepatocellular injury—Thalidomide—leprosy	0.00703	0.00862	CcSEcCtD
Ramipril—Blood urea increased—Thalidomide—leprosy	0.00664	0.00814	CcSEcCtD
Ramipril—Neuropathy—Thalidomide—leprosy	0.0066	0.0081	CcSEcCtD
Ramipril—Tinnitus—Dapsone—leprosy	0.00643	0.00789	CcSEcCtD
Ramipril—Rash maculo-papular—Thalidomide—leprosy	0.00639	0.00784	CcSEcCtD
Ramipril—Lightheadedness—Thalidomide—leprosy	0.00629	0.00772	CcSEcCtD
Ramipril—Gynaecomastia—Thalidomide—leprosy	0.00629	0.00772	CcSEcCtD
Ramipril—Erythema—Dapsone—leprosy	0.00601	0.00736	CcSEcCtD
Ramipril—Photosensitivity—Thalidomide—leprosy	0.00581	0.00713	CcSEcCtD
Ramipril—Gastroenteritis—Thalidomide—leprosy	0.00576	0.00706	CcSEcCtD
Ramipril—Deafness—Thalidomide—leprosy	0.00571	0.007	CcSEcCtD
Ramipril—Vascular purpura—Thalidomide—leprosy	0.00571	0.007	CcSEcCtD
Ramipril—Renal failure acute—Thalidomide—leprosy	0.00553	0.00678	CcSEcCtD
Ramipril—Libido decreased—Thalidomide—leprosy	0.00551	0.00675	CcSEcCtD
Ramipril—Amnesia—Thalidomide—leprosy	0.00543	0.00666	CcSEcCtD
Ramipril—Dermatitis exfoliative—Thalidomide—leprosy	0.00541	0.00663	CcSEcCtD
Ramipril—Vertigo—Dapsone—leprosy	0.0054	0.00662	CcSEcCtD
Ramipril—Atrial fibrillation—Thalidomide—leprosy	0.00539	0.00661	CcSEcCtD
Ramipril—Purpura—Thalidomide—leprosy	0.0053	0.0065	CcSEcCtD
Ramipril—Arthritis—Thalidomide—leprosy	0.00525	0.00644	CcSEcCtD
Ramipril—Cough—Dapsone—leprosy	0.00524	0.00643	CcSEcCtD
Ramipril—Cardiac failure—Thalidomide—leprosy	0.00523	0.00641	CcSEcCtD
Ramipril—Hypoglycaemia—Thalidomide—leprosy	0.00523	0.00641	CcSEcCtD
Ramipril—Cerebrovascular accident—Thalidomide—leprosy	0.00521	0.00639	CcSEcCtD
Ramipril—BCHE—skin of body—leprosy	0.00518	0.0281	CbGeAlD
Ramipril—Hyponatraemia—Thalidomide—leprosy	0.00513	0.00629	CcSEcCtD
Ramipril—Disturbance in sexual arousal—Thalidomide—leprosy	0.00506	0.00621	CcSEcCtD
Ramipril—Tachycardia—Dapsone—leprosy	0.00478	0.00587	CcSEcCtD
Ramipril—Blood creatinine increased—Thalidomide—leprosy	0.00478	0.00586	CcSEcCtD
Ramipril—Liver function test abnormal—Thalidomide—leprosy	0.00471	0.00578	CcSEcCtD
Ramipril—Orthostatic hypotension—Thalidomide—leprosy	0.00466	0.00572	CcSEcCtD
Ramipril—Breast disorder—Thalidomide—leprosy	0.00461	0.00566	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Thalidomide—leprosy	0.0046	0.00564	CcSEcCtD
Ramipril—Cramp muscle—Thalidomide—leprosy	0.0046	0.00564	CcSEcCtD
Ramipril—Insomnia—Dapsone—leprosy	0.00443	0.00544	CcSEcCtD
Ramipril—ACE—testis—leprosy	0.00442	0.024	CbGeAlD
Ramipril—Influenza—Thalidomide—leprosy	0.00441	0.00541	CcSEcCtD
Ramipril—Dysphagia—Thalidomide—leprosy	0.00441	0.00541	CcSEcCtD
Ramipril—Eosinophilia—Thalidomide—leprosy	0.00437	0.00536	CcSEcCtD
Ramipril—Bronchospasm—Thalidomide—leprosy	0.00434	0.00532	CcSEcCtD
Ramipril—ACE—nervous system—leprosy	0.00434	0.0235	CbGeAlD
Ramipril—Pancreatitis—Thalidomide—leprosy	0.00433	0.00531	CcSEcCtD
Ramipril—Angina pectoris—Thalidomide—leprosy	0.0043	0.00527	CcSEcCtD
Ramipril—Bronchitis—Thalidomide—leprosy	0.00424	0.0052	CcSEcCtD
Ramipril—Pancytopenia—Thalidomide—leprosy	0.00419	0.00514	CcSEcCtD
Ramipril—Neutropenia—Thalidomide—leprosy	0.00413	0.00506	CcSEcCtD
Ramipril—Upper respiratory tract infection—Thalidomide—leprosy	0.0041	0.00503	CcSEcCtD
Ramipril—Erectile dysfunction—Thalidomide—leprosy	0.00406	0.00498	CcSEcCtD
Ramipril—Photosensitivity reaction—Thalidomide—leprosy	0.00403	0.00494	CcSEcCtD
Ramipril—Weight increased—Thalidomide—leprosy	0.00402	0.00492	CcSEcCtD
Ramipril—Gastrointestinal pain—Dapsone—leprosy	0.00401	0.00492	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Thalidomide—leprosy	0.0039	0.00478	CcSEcCtD
Ramipril—Acute coronary syndrome—Thalidomide—leprosy	0.00388	0.00476	CcSEcCtD
Ramipril—Abdominal pain—Dapsone—leprosy	0.00387	0.00475	CcSEcCtD
Ramipril—Body temperature increased—Dapsone—leprosy	0.00387	0.00475	CcSEcCtD
Ramipril—Renal failure—Thalidomide—leprosy	0.00387	0.00474	CcSEcCtD
Ramipril—Neuropathy peripheral—Thalidomide—leprosy	0.00386	0.00473	CcSEcCtD
Ramipril—Myocardial infarction—Thalidomide—leprosy	0.00386	0.00473	CcSEcCtD
Ramipril—SLC15A2—testis—leprosy	0.00386	0.0209	CbGeAlD
Ramipril—Stomatitis—Thalidomide—leprosy	0.00383	0.0047	CcSEcCtD
Ramipril—Conjunctivitis—Thalidomide—leprosy	0.00382	0.00469	CcSEcCtD
Ramipril—SLC15A2—nervous system—leprosy	0.00378	0.0205	CbGeAlD
Ramipril—Sweating—Thalidomide—leprosy	0.00377	0.00463	CcSEcCtD
Ramipril—Epistaxis—Thalidomide—leprosy	0.00371	0.00455	CcSEcCtD
Ramipril—Sinusitis—Thalidomide—leprosy	0.00369	0.00453	CcSEcCtD
Ramipril—Agranulocytosis—Thalidomide—leprosy	0.00367	0.0045	CcSEcCtD
Ramipril—Hepatitis—Thalidomide—leprosy	0.00353	0.00433	CcSEcCtD
Ramipril—Oedema peripheral—Thalidomide—leprosy	0.00348	0.00427	CcSEcCtD
Ramipril—Visual impairment—Thalidomide—leprosy	0.0034	0.00417	CcSEcCtD
Ramipril—Erythema multiforme—Thalidomide—leprosy	0.00334	0.00409	CcSEcCtD
Ramipril—Tinnitus—Thalidomide—leprosy	0.00329	0.00404	CcSEcCtD
Ramipril—BCHE—testis—leprosy	0.00327	0.0177	CbGeAlD
Ramipril—BCHE—nervous system—leprosy	0.00321	0.0174	CbGeAlD
Ramipril—Immune system disorder—Thalidomide—leprosy	0.00319	0.00391	CcSEcCtD
Ramipril—Mediastinal disorder—Thalidomide—leprosy	0.00318	0.0039	CcSEcCtD
Ramipril—Arrhythmia—Thalidomide—leprosy	0.00316	0.00387	CcSEcCtD
Ramipril—Alopecia—Thalidomide—leprosy	0.00312	0.00383	CcSEcCtD
Ramipril—Vomiting—Dapsone—leprosy	0.00312	0.00382	CcSEcCtD
Ramipril—Mental disorder—Thalidomide—leprosy	0.00309	0.00379	CcSEcCtD
Ramipril—Malnutrition—Thalidomide—leprosy	0.00307	0.00377	CcSEcCtD
Ramipril—Headache—Dapsone—leprosy	0.00307	0.00377	CcSEcCtD
Ramipril—Tension—Thalidomide—leprosy	0.00302	0.0037	CcSEcCtD
Ramipril—Dysgeusia—Thalidomide—leprosy	0.00301	0.00369	CcSEcCtD
Ramipril—Nervousness—Thalidomide—leprosy	0.00299	0.00366	CcSEcCtD
Ramipril—Muscle spasms—Thalidomide—leprosy	0.00296	0.00362	CcSEcCtD
Ramipril—Nausea—Dapsone—leprosy	0.00291	0.00357	CcSEcCtD
Ramipril—Tremor—Thalidomide—leprosy	0.00288	0.00353	CcSEcCtD
Ramipril—Ill-defined disorder—Thalidomide—leprosy	0.00285	0.0035	CcSEcCtD
Ramipril—Agitation—Thalidomide—leprosy	0.00283	0.00346	CcSEcCtD
Ramipril—Angioedema—Thalidomide—leprosy	0.00281	0.00344	CcSEcCtD
Ramipril—Malaise—Thalidomide—leprosy	0.00277	0.0034	CcSEcCtD
Ramipril—Vertigo—Thalidomide—leprosy	0.00276	0.00339	CcSEcCtD
Ramipril—Syncope—Thalidomide—leprosy	0.00276	0.00338	CcSEcCtD
Ramipril—Leukopenia—Thalidomide—leprosy	0.00275	0.00337	CcSEcCtD
Ramipril—Palpitations—Thalidomide—leprosy	0.00272	0.00333	CcSEcCtD
Ramipril—Loss of consciousness—Thalidomide—leprosy	0.0027	0.00331	CcSEcCtD
Ramipril—Cough—Thalidomide—leprosy	0.00268	0.00329	CcSEcCtD
Ramipril—Convulsion—Thalidomide—leprosy	0.00266	0.00327	CcSEcCtD
Ramipril—Chest pain—Thalidomide—leprosy	0.00262	0.00321	CcSEcCtD
Ramipril—Myalgia—Thalidomide—leprosy	0.00262	0.00321	CcSEcCtD
Ramipril—Arthralgia—Thalidomide—leprosy	0.00262	0.00321	CcSEcCtD
Ramipril—Anxiety—Thalidomide—leprosy	0.00261	0.0032	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.0026	0.00319	CcSEcCtD
Ramipril—Discomfort—Thalidomide—leprosy	0.00259	0.00317	CcSEcCtD
Ramipril—Dry mouth—Thalidomide—leprosy	0.00256	0.00314	CcSEcCtD
Ramipril—Confusional state—Thalidomide—leprosy	0.00253	0.0031	CcSEcCtD
Ramipril—Oedema—Thalidomide—leprosy	0.00251	0.00308	CcSEcCtD
Ramipril—Shock—Thalidomide—leprosy	0.00247	0.00303	CcSEcCtD
Ramipril—Nervous system disorder—Thalidomide—leprosy	0.00246	0.00302	CcSEcCtD
Ramipril—Thrombocytopenia—Thalidomide—leprosy	0.00246	0.00301	CcSEcCtD
Ramipril—Tachycardia—Thalidomide—leprosy	0.00245	0.003	CcSEcCtD
Ramipril—Skin disorder—Thalidomide—leprosy	0.00244	0.00299	CcSEcCtD
Ramipril—Hyperhidrosis—Thalidomide—leprosy	0.00243	0.00297	CcSEcCtD
Ramipril—Anorexia—Thalidomide—leprosy	0.00239	0.00293	CcSEcCtD
Ramipril—Hypotension—Thalidomide—leprosy	0.00234	0.00288	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Thalidomide—leprosy	0.00229	0.0028	CcSEcCtD
Ramipril—Insomnia—Thalidomide—leprosy	0.00227	0.00278	CcSEcCtD
Ramipril—Paraesthesia—Thalidomide—leprosy	0.00225	0.00276	CcSEcCtD
Ramipril—Dyspnoea—Thalidomide—leprosy	0.00224	0.00274	CcSEcCtD
Ramipril—Somnolence—Thalidomide—leprosy	0.00223	0.00274	CcSEcCtD
Ramipril—Dyspepsia—Thalidomide—leprosy	0.00221	0.00271	CcSEcCtD
Ramipril—Decreased appetite—Thalidomide—leprosy	0.00218	0.00267	CcSEcCtD
Ramipril—Gastrointestinal disorder—Thalidomide—leprosy	0.00217	0.00266	CcSEcCtD
Ramipril—Fatigue—Thalidomide—leprosy	0.00216	0.00265	CcSEcCtD
Ramipril—Constipation—Thalidomide—leprosy	0.00215	0.00263	CcSEcCtD
Ramipril—Feeling abnormal—Thalidomide—leprosy	0.00207	0.00254	CcSEcCtD
Ramipril—Gastrointestinal pain—Thalidomide—leprosy	0.00205	0.00252	CcSEcCtD
Ramipril—Urticaria—Thalidomide—leprosy	0.00199	0.00244	CcSEcCtD
Ramipril—Abdominal pain—Thalidomide—leprosy	0.00198	0.00243	CcSEcCtD
Ramipril—Body temperature increased—Thalidomide—leprosy	0.00198	0.00243	CcSEcCtD
Ramipril—Hypersensitivity—Thalidomide—leprosy	0.00185	0.00227	CcSEcCtD
Ramipril—Asthenia—Thalidomide—leprosy	0.0018	0.00221	CcSEcCtD
Ramipril—Pruritus—Thalidomide—leprosy	0.00178	0.00218	CcSEcCtD
Ramipril—Diarrhoea—Thalidomide—leprosy	0.00172	0.00211	CcSEcCtD
Ramipril—Dizziness—Thalidomide—leprosy	0.00166	0.00203	CcSEcCtD
Ramipril—Vomiting—Thalidomide—leprosy	0.0016	0.00196	CcSEcCtD
Ramipril—Rash—Thalidomide—leprosy	0.00158	0.00194	CcSEcCtD
Ramipril—Dermatitis—Thalidomide—leprosy	0.00158	0.00194	CcSEcCtD
Ramipril—Headache—Thalidomide—leprosy	0.00157	0.00193	CcSEcCtD
Ramipril—Nausea—Thalidomide—leprosy	0.00149	0.00183	CcSEcCtD
